Reaction
Left Ventricular Dilatation reporting signals
As of the last recalculation, Left Ventricular Dilatation appears in 494 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is EPLERENONE (PRR 90.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eplerenone | 26 | 90.2 | 90.4 |
| Nevirapine | 17 | 82.2 | 82.3 |
| Ado-Trastuzumab Emtansine | 14 | 72.0 | 72.1 |
| Atazanavir | 22 | 67.5 | 67.6 |
| Darunavir | 19 | 55.0 | 55.1 |
| Dexamethasone Sodium Phosphate | 9 | 38.0 | 38.0 |
| Ritonavir | 21 | 31.6 | 31.6 |
| Doxorubicin Hydrochloride | 22 | 29.7 | 29.7 |
| Norepinephrine | 7 | 28.0 | 28.0 |
| Bleomycin Sulfate | 6 | 24.8 | 24.8 |
| Trastuzumab | 31 | 20.2 | 20.2 |
| Doxorubicin | 36 | 18.3 | 18.3 |
| Tafamidis | 5 | 18.1 | 18.1 |
| Pertuzumab | 11 | 17.4 | 17.4 |
| Sacubitril And Valsartan | 41 | 16.1 | 16.1 |